News archive for Department of Clinical Medicine

12 mill NOK was today (Dec. 20, 2024) awarded to Lars A. Akslen and Heidrun Vethe from the Research Council of Norway (FRIPRO) on the project "When breast cancer hits a nerve - neural involvement as a hallmark of tumor progression."

CCBIO has a tradition of using the December meeting in its seminar series to add a different perspective and encourage our research environment to think outside of the box. This December, we had the pleasure of welcoming back Fran Balkwill, who has a unique experience in addition to her cancer research career.

CCBIO recently held its signature course Methods in Cancer Biomarker Research (CCBIO905), September 25-27, 2024, at Haukeland University Hospital, providing the attending students with a full panel of standard and advanced methods with relevance for cancer biomarker research.

Neuro-SysMed hosted its 2nd Annual Symposium on September 30 and October 1, 2024, at the historic Solstrand Hotel near Bergen, gathering 125 participants from various fields of neurological research. Among the distinguished guest speakers were EBV-MS Scientific Advisory Board Member Professor Gavin Giovannoni and EBV-MS Partner, Assistant Professor Kjetil Bjørnevik.

This meeting at Solstrand August 28–31, 2024 was the 2nd Research Meeting in the INTPART collaboration between CCBIO and the Vascular Biology Program (VBP), Boston Children’s Hospital and Harvard Medical School, the first being the Iceland meeting in 2019. In 2019, 48 participants met in Iceland, and this year, 57 gathered at Solstrand.

Kari Strøno Wagner-Larsen defended November 15, 2024 her doctoral work at the University of Bergen with the thesis "Advanced MRI for developing more personalized treatment strategies in uterine cervical cancer". Wagner-Larsen's doctoral work includes four studies showing that traditional as well as advanced, computer-assisted MRI analyses (radiomics) improve the risk assessment of patients with... Read more

Sturla Magnus Grøndal completed his PhD October 14, 2024 at the University of Bergen with his doctoral work "Mechanisms of Immune Dysregulation through AXL Receptor Tyrosine Kinase Signaling in Cancer and Fibrotic Diseases".

Austin James Rayford completed October 11, 2024 his PhD degree at the University in Bergen with his thesis "Studies on the effect of AXL inhibition in non-small cell lung cancer".